WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ: CLZR) today announced the jury in the U.S. District Court for the Eastern District of Texas – Lufkin Division ruled in favor of Palomar in a patent infringement lawsuit brought by Candela against Palomar Medical Technologies, Inc. (NASDAQ: PMTI) in December 2006. The jury ruled that Palomar did not infringe upon Candela’s 5,810,801 patent and that claims 11, 12, 13 and 14 of the 5,810,801 patent are invalid.
